Term
Retrospective Utilizaton
Agregate therapies |
|
Definition
Retrospective Utilizaton: look back at old therapies
Agregate therapies: modify |
|
|
Term
|
Definition
|
|
Term
|
Definition
50% 50%
270K in 2008
200K practicing
65% community, 20% hospital, 15% other
|
|
|
Term
|
Definition
Male
Doc
Compounding
soda fountain
on the corner
independent |
|
|
Term
|
Definition
Smarter
pre packaged doses
more females
more minorities
Pharm D (2005)
front end stuff
near mall
chains hire 55% |
|
|
Term
|
Definition
catagory of "sales". posibility to move up
6/10 pharmacists in community setting
Chain Drugstores:
Chain food stores:
Chain mass merchendise:
Franchise: Medicine shop
independents
hospital outpatient
mail order
internet |
|
|
Term
|
Definition
4B #Rx
300.3B $
chans: 60%
independent: 15%
mail order: 20% |
|
|
Term
|
Definition
| medicare/medicade requires nursing homes to review drugs. contract to pharmacist |
|
|
Term
|
Definition
Patient
Prescriber
Pharmacy
Producer (manufacture)
Purveyor (Wholesaler)
Payor (often not PT)
|
|
|
Term
med costs
AWP
Dispensing fee |
|
Definition
TP decides reinbursement price
Pharmacy decides cash price
AWP: average wholesale price price (in bulk) from wholesaler. insurer estimates AWP and discount, and pays pharmacy
Dispensing Fee: expense/# Rx |
|
|
Term
|
Definition
"Medical care benefit & drug benefits not conected"
gives drug benefit programs for employers and health insurence cariers
work to maximize effectiveness, minimize costs
manage pharmacy benefits, control cost through
Price: decide formulary, tiered copay, ingredient cost, dispensing fees, rebates
Utilization: quantity, DUR, PA,
Drug Mix: generic sub, therapy change, step therapy
Other: disease management, mail order |
|
|
Term
|
Definition
1906
aprove safety 1938
aprove efficiency 1962
aprove devices 1976
Modrnization act 1997: more info/off lable uses |
|
|
Term
| drugs tested absolutely, not in relation to other drugs |
|
Definition
"absolute approval"
"me too drugs" |
|
|
Term
|
Definition
1. animal test
2. investigative new drug (ING) application
3. human testing 1 2 3(bigger groups)
4 New Drug Application (NDA)
5 OK to market
process 7-15 years
6. post marketing studies |
|
|
Term
|
Definition
cost,
off lable use,
Direct to consumer Advertising (DTC)
Biotech
new drugs made |
|
|
Term
|
Definition
60%
80 classes 100K.
inapropriate prescribing/dispensing/use
|
|
|
Term
|
Definition
research 20%
manufacturing 15%
advertising 30%
taxes 15%
PROFIT 20% |
|
|
